Delivery Order SPE2DB24D9223-SPE2DB25FKELD
- Not listed
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Avastin 400 mg/16 mL vials with a ceiling value of $8,709.44. This delivery order, awarded on July 24, 2025, represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation, and the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,728.70 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order covers the supply of Avastin 100 mg/4 mL vials and was issued without a set-aside designation. The contract was awarded under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a delivery order valued at $17,418.88 to DMS Pharmaceutical Group Inc. for Avastin 400 mg/16 ml vials on September 8, 2025, with completion expected by September 29, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Avastin is a branded bevacizumab product used in oncology treatment, reflecting the Defense Logistics Agency's ongoing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,721.84 firm fixed-price delivery order is for the supply of Avastin (bevacizumab) 400 mg/16 mL vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a delivery order valued at $2,291.48 to DMS Pharmaceutical Group Inc. for the supply of Avastin 100 mg/4 mL vials on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $54,137.40, is for the delivery of Avastin 400 mg/16 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,870.08 contract is for the delivery of Avastin 400 mg/16 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,827.48 contract is for the delivery of Avastin 400 mg/16 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
- This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,416.34, is for the delivery of Avastin 100 mg/4 ml vial 4 ml to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,387.80 contract is for the delivery of Avastin 100 mg/4 ml vials and has an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKELDDelivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Avastin 400 mg/16 ml vials. The contract, valued at $8,709.44 under a firm fixed-price arrangement, is scheduled for completion by September 23, 2025, with an award date of September 2, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a full and open basis despite its small business status. The place of performance is located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026 under the SPE2DB program. The IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. Avastin, a specialty oncology medication, represents part of the extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group provides through this contract vehicle to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/2/25 |